Long-term clinical effects of intravitreal injections of conbercept for the treatment of choroidal neovascularization in patients with pathological myopia

Long-term clinical effects of intravitreal injections of conbercept for the treatment of choroidal neovascularization in patients with pathological myopia

AIM: To observe the long-term clinical efficacy of intravitreal injections of conbercept, a novel vascular growth factor inhibitor, for the treatment of pathological myopia choroidal neovascularization (PM-CNV). METHODS: A total of 67 eyes (from 67 patients; mean age, 54.90±12.7y) with PM-CNV were r...

Full description

Bibliographic Details
Main Authors:	Si Zhang, Zi-Fang He, Fei-Fei Chen, Wen-Wen Zhang, Ya-Jun Liu, Hui Chen, Zheng-Gao Xie
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2022-12-01
Series:	International Journal of Ophthalmology
Subjects:	pathological myopia choroidal neovascularization conbercept best-corrected visual acuity central macular thickness
Online Access:	http://ies.ijo.cn/en_publish/2022/12/20221212.pdf

Similar Items

Short-term effects of intravitreal Conbercept for choroidal neovascularization secondary to high myopia
by: Jie-Yun He, et al.
Published: (2018-12-01)

Intravitreal Conbercept or Ranibizumab for myopic choroidal neovascularization
by: Cai-Yun Zhang, et al.
Published: (2022-06-01)

Curative effect of compound Xuesaitong combined with Conbercept in the treatment of choroidal neovascularization in pathological myopia
by: He-Ling Huang, et al.
Published: (2017-06-01)

Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
by: Chuan-bin Sun, et al.
Published: (2019-07-01)

Effect analysis of the intravitreal Conbercept in the treatment of choroid neovascularization of macular with high myopia
by: Hui-Xuan Ren, et al.
Published: (2021-06-01)

Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China
by: Xin Nie, et al.
Published: (2021-03-01)

Outcomes of Conbercept therapy for choroidal neovascularization secondary to pathological myopia
by: Zheng-Feng Liu, et al.
Published: (2020-12-01)

Intravitreal Conbercept therapy for choroidal neovascularization due to high myopia
by: Yan-Jie Xie, et al.
Published: (2018-02-01)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021-10-01)

Efficacy of Conbercept in the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia
by: Hui Lu, et al.
Published: (2021-10-01)

Comparison of the efficacy of two Conbercept regimens in the treatment of polypoid choroidal angiopathy
by: Zhou-Peng Liao, et al.
Published: (2020-03-01)

Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept
by: Yin Xue, et al.
Published: (2022-02-01)

Effect of intravitreal injection of conbercept on neovascular age-related macular degeneration
by: Tao Li, et al.
Published: (2019-04-01)

Successful Use of Conbercept to Treat Choroidal Neovascularization: A Case Report
by: Jin Yang, et al.
Published: (2022-11-01)

Clinical effect of Conbercept intravitreal injection combined with 577nm micro-pulse laser on the treatment of diabetic macular edema
by: Guo-Peng Ding, et al.
Published: (2015-11-01)

Preliminary study of Conbercept injected intravitreally for the treatment of wet age-related macular degeneration
by: Ying Qin, et al.
Published: (2017-08-01)

Therapeutic effect and safety of conbercept intravitreal injection combined with selective laser photocoagulation on CRVO
by: Ju Huang, et al.
Published: (2019-05-01)

Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01)

Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review
by: Wei-Shai Liu, et al.
Published: (2019-09-01)

Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
by: İrfan Perente, et al.
Published: (2018-04-01)

Efficacy and safety of intravitreal injections of conbercept for the treatment of idiopathic choroidal neovascularization
by: Gaixia Zhai, et al.
Published: (2024-02-01)

Analysis on macular choroidal thickness of patients with myopic choroidal neovascularization
by: Yan Qiu, et al.
Published: (2015-05-01)

Co-existent choroidal neovascular membrane and macular hole in pathologic myopia:a long follow-up clinical outcome and literature review
by: Zhi-Qing Chen, et al.
Published: (2013-12-01)

Comparison of the outcome of limited protocol Ranibizumab injection in naïve choroidal neovascular membranes secondary to pathological myopia versus age-related macular degeneration
by: Samah M Fawzy, et al.
Published: (2023-01-01)

Efficacy of intravitreal Ranibizumab injection for choroidal neovascularization secondary to pathologic myopia
by: Li-Hong Cui, et al.
Published: (2016-03-01)

Progress of the application of Conbercept in ocular neovascular diseases
by: Xiao-Dong Chen, et al.
Published: (2022-08-01)

Morphologic Features of Myopic Choroidal Neovascularization in Pathologic Myopia on Swept-Source Optical Coherence Tomography
by: Jiamin Xie, et al.
Published: (2020-12-01)

Effect of intravitreal Conbercept on wet age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ying-Chun Li, et al.
Published: (2015-11-01)

Curative effect of intravitreal injection of Conbercept on BRVO-ME and influencing factors of best corrected visual acuity after treatment
by: Jian-Zhi Qiao, et al.
Published: (2019-08-01)

Recent advance on anti-VEGF treatment of choroidal neovascularization secondary to pathological myopia
by: Xing-Zhao Xu, et al.
Published: (2018-09-01)

Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy
by: Yuting Peng, et al.
Published: (2017-06-01)

Effect of Conbercept on treating polypoidal choroidal vasculopathy and its effect on hemorheology of patients
by: Ayinu·Nulahou, et al.
Published: (2020-04-01)

Clinical observation of intravitreal injection of Conbercept treating diabetic macularedema
by: Li Jiang, et al.
Published: (2017-06-01)

Effect of vitrectomy with intravitreal Conbercept injection for polypoidal choroidal vasculopathy associated with vitreous hemorrhage
by: Jian Shen, et al.
Published: (2018-09-01)

ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
by: S. A. Korotkikh, et al.
Published: (2016-11-01)

Changes of subfoveal choroidal thickness after treated by Ranibizumab for choroidal neovascularization secondary to pathologic myopia
by: Jian-Shu Yuan, et al.
Published: (2016-05-01)

Intravitreal injection of Conbercept combined with trabeculectomy and panretinal photocoagulation for the treatment of neovascular glaucoma
by: Zhe Yu, et al.
Published: (2018-05-01)

Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions
by: Ding X, et al.
Published: (2022-09-01)

Functional and subfoveal choroidal thickness correlation analysis before and after surgery in patients with macular epiretinal membrane
by: Hong-Bo Zeng, et al.
Published: (2019-04-01)

Observation of the macular thickness after the treatment of choroidal neovascularization with pathological myopia
by: Li Yan, et al.
Published: (2018-02-01)